Find a Tender
planned
Official procurement procedure
Rapid Molecular Testing Service for Public Health Wales
Laboratory reagents
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust): "Rapid Molecular Testing Service for Public Health Wales". Published status: planned. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | Scope & Categories | Not published | Submission Window | planned No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
1.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 443 active published awards; 365 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statusplanned | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published2 Feb 2023, 16:12 GMT | Last source update2 Feb 2023, 16:12 GMT | Recurring procurementNot published |
ClassificationLaboratory reagents | ||
Delivery area | ||
OCIDocds-h6vhtk-03a27d | ||
What is being bought
Public Health Wales, in advance of a tender, would like to invite companies to provide their bespoke options for a rapid molecular service based on 2 lots for Wales at a user engagement session on the 27th February 2023 at Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ.
-Lot 1 being essential supporting pneumonia and meningoencephalitis syndromic algorithm.
-Lot 2 being desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm.
Interested parties will be offered a user engagement session, further details available from the contracting authority.
What changed
From the official release history
- Status changed to planned
2 Feb 2023, 16:12 GMT - Official notice release published
2 Feb 2023, 16:12 GMT - Buyer information updated
2 Feb 2023, 16:12 GMT
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1Essential supporting pneumonia and meningoencephalitis syndromic algorithm.plannedPublished valueNot publishedEssential supporting pneumonia and meningoencephalitis syndromic algorithm. * Offer must include all instruments, consumables, reagent, support, service and maintenance. * Consideration needs to be taken into capital money investment by Welsh Government in new equipment (BioFire Film Arrays; ePlex and Cepheid) to support rapid diagnosis in the pandemic as these still have an expected shelf life of another 5 years. * In addition, we have some reagent rental instruments in the Network. * Minimal processing time will be required for specimen investigation. * Speed of turnaround time for result will be essential. * Multiplex will be preferred over singleplex targets. * Software interpretation of result and interface to LIMS is essential. * High negative predictive, Sensitivity and Specificity is essential. * Reduce the need for specialist technical interpretation and handling. * Instruments and associated reagents must be complaint with UK Quality marking for equipment, reagents and consumables. * The service is to be fully functional by 1st July 2023. * The current estimates on numbers is a minimum of 20 rapid test per site in the network. * There are 12 Public Health Wales sites with potential to include 3 non-Public Health Wales sites. * Maintain and provide the ability to meet the increase demand and a robust supply chain. * Support our adherence to antibiotic sensitivity testing and reporting guidelines.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm.plannedPublished valueNot publishedDesirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. * Offer must include all instruments, consumables, reagent, support, service and maintenance. * Consideration needs to be taken into capital money investment by Welsh Government in new equipment (BioFire Film Arrays; ePlex and Cepheid) to support rapid diagnosis in the pandemic as these still have an expected shelf life of another 5 years. * In addition, we have some reagent rental instruments in the Network. * Minimal processing time will be required for specimen investigation. * Health and Safety during the processing must minimise any potential incident, hazard or risk. * Speed of turnaround time for result will be essential. * Multiplex will be preferred over singleplex targets. * Software interpretation of result and interface to LIMS is essential. * High negative predictive, Sensitivity and Specificity is essential. * Reduce the need for specialist technical interpretation and handling. * Instruments and associated reagents must be complaint with UK Quality marking for equipment, reagents and consumables. * The service is to be fully functional by 1st July 2023. * The current estimates on numbers is a minimum of 20 rapid test per site in the network. * There are 12 Public Health Wales sites with potential to include 3 non-Public Health Wales sites. * Maintain and provide the ability to meet the increase demand and a robust supply chain. * Support our adherence to antibiotic sensitivity testing and reporting guidelines. * A robust and resilient support post service implementation.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
2 Feb 2023, 16:12 GMT
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Contracting authority GB-FTS-109Documents (2)
Official links; attachments are not copied
Related procedures (0)
No related procedures published